Elimination of IDO activity was found to improve the outcome of sepsis, certain viral infections, chronic inflammation linked to diabetes, obesity, aorta aneurysm formation, and in anti-tumoral processes. This evidence concerns the gene IDO1 and obesity due to melanocortin 4 receptor deficiency.